Bio-Works Technologies AB Revenue and Competitors
Estimated Revenue & Valuation
- Bio-Works Technologies AB's estimated annual revenue is currently $11.9M per year.
- Bio-Works Technologies AB's estimated revenue per employee is $155,000
- Bio-Works Technologies AB has 77 Employees.
- Bio-Works Technologies AB grew their employee count by 8% last year.
Bio-Works Technologies AB Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Bio-Works Technologies AB?
Bio-Works was founded in 2006 and is involved in R&D, manufacturing and supply of innovative, leading edge products used to separate proteins and other biomolecules. Our staff is rich in experience within the Swedish Life science industry and are specialized in resins for separation and purification. Bio-Works' research, development and production facilities are located in Uppsala, Sweden. We are actively working with sustainable development and our Quality Management System is based on ISO 9001:2015 standards. Bio-Works produces agarose based products with exceptional performance. These are used in academic research laboratories, biopharmaceutical companies, the Food & Beverage industry and many more areas.keywords:N/A
Number of Employees
Employee Growth %
Bio-Works Technologies AB News
Cambridge, U.K.-based Arecor has a formulation technology that it hopes ... Ocuphire, Opiant, Promis, Serenity Bioworks, Sio Gene Therapies,...
Bio-Works Technologies AB har idag publicerat sin årsredovisning för 2021. Rapporten finns tillgänglig på bolagets hemsida www.bio-works.com...
Uppdatering Q1 2022. Idag rapporterar Bio-Works Technologies AB försäljningen för det första kvartalet 2022, ett starkt kvartal...
Bio-Works confirms new order from Nemysis Limited worth 2.1 million SEK Tue, Sep 28, 2021 13:58 CET Bio-Works Technologies AB has confirmed that they have received a new order from Nemysis Limited, an Irish based company developing enzymatic solutions for gluten intolerance. The order, worth €2 ...
Amicogen Inc enters into agreement to divest its ownership in Bio-Works Fri, Sep 10, 2021 13:47 CET Amicogen Inc. has entered into an agreement to divest its ownership in Bio-Works Technologies AB (BIOWKS.ST). Amicogen's entire holding of 3,007,896 shares was sold today at 12:03:42 CET in a tra ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|